C. Martin Harris - Feb 21, 2023 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role
Director
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Stock symbol
CL
Transactions as of
Feb 21, 2023
Transactions value $
-$14,827
Form type
4
Date filed
2/23/2023, 03:14 PM
Previous filing
May 24, 2022
Next filing
Mar 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $409K +5.7K +33.53% $71.65 22.7K Feb 21, 2023 Direct F1
transaction CL Common Stock Sale -$423K -5.7K -25.11% $74.25 17K Feb 21, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -5.7K -100% $0.00* 0 Feb 21, 2023 Common Stock 5.7K $71.65 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $74.2400 to $74.2600, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Option became exercisable in one-third increments beginning on the first anniversary of the May 15, 2017 grant date.